The anti-PD-L1 therapeutic antibodies have demonstrated significant antitumor activity in ABC, suggesting that immune checkpoints have a significant impact on BC metastatic cascades; No single drug treatment can permanently eliminate the tumor, according to many studies (37). This evidence concerns the gene CD274 and breast cancer.